These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9000261)

  • 1. Progesterone modulation of diazepam withdrawal syndrome in mice.
    Pesce ME; Acevedo X; Pinardi G; Miranda HF
    Pharmacol Toxicol; 1996 Dec; 79(6):331-3. PubMed ID: 9000261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.
    Reddy DS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997; 19(6):395-405. PubMed ID: 9385589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in diazepam withdrawal syndrome in mice.
    Pesce ME; Acevedo X; Pinardi G; Miranda HF
    Pharmacol Toxicol; 1994 Dec; 75(6):353-5. PubMed ID: 7899256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of sex differences in anxiety behaviors during precipitated benzodiazepine withdrawal in rats.
    Stock H; Ford K; Biscardi R; Wilson MA
    Physiol Behav; 1999 Mar; 66(1):125-30. PubMed ID: 10222484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes.
    Allison C; Claase LA; Pratt JA
    Behav Pharmacol; 2002 Sep; 13(5-6):417-25. PubMed ID: 12394418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazepam-treated female rats: flumazenil- and PK 11195-induced withdrawal in the hippocampus CA1.
    Sloan JW; Wala E; Jing X; Holtman JR; Milliken B
    Pharmacol Biochem Behav; 1998 Sep; 61(1):121-30. PubMed ID: 9715814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats.
    Divljaković J; Milić M; Namjoshi OA; Tiruveedhula VV; Timić T; Cook JM; Savić MM
    Brain Res Bull; 2013 Feb; 91():1-7. PubMed ID: 23149168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone withdrawal I: pro-convulsant effects.
    Moran MH; Smith SS
    Brain Res; 1998 Oct; 807(1-2):84-90. PubMed ID: 9757004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benzodiazepines: anxiolytic and withdrawal effects.
    Little HJ
    Neuropeptides; 1991 Jul; 19 Suppl():11-4. PubMed ID: 1679209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does dihydrohonokiol, a potent anxiolytic compound, result in the development of benzodiazepine-like side effects?
    Kuribara H; Kishi E; Maruyama Y
    J Pharm Pharmacol; 2000 Aug; 52(8):1017-22. PubMed ID: 11007074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamics of PK 11195 in diazepam-dependent male and female rats.
    Sloan JW; Wala EP; Jing X; Holtman JR
    Pharmacol Biochem Behav; 2000 Aug; 66(4):751-64. PubMed ID: 10973513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):259-67. PubMed ID: 15452683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra: the involvement of central and peripheral benzodiazepine receptors in physical dependence on diazepam as evidenced by behavioral and EEG effects.
    Wala EP; Sloan JW; Jing X
    Pharmacol Biochem Behav; 1999 Nov; 64(3):611-23. PubMed ID: 10548279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity.
    Ward BO; Stephens DN
    Psychopharmacology (Berl); 1998 Feb; 135(4):342-52. PubMed ID: 9539258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
    Listos J; Malec D; Fidecka S
    Eur J Pharmacol; 2005 Oct; 523(1-3):71-8. PubMed ID: 16226742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective discriminative stimulus effects of zopiclone in rhesus monkeys.
    McMahon LR; Jerussi TP; France CP
    Psychopharmacology (Berl); 2003 Jan; 165(3):222-8. PubMed ID: 12434260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different location of benzodiazepine sites involved in gut and behavioral effects of benzodiazepine withdrawal in rats.
    Bonnafous C; Bueno L
    Pharmacol Biochem Behav; 1994 Sep; 49(1):253-6. PubMed ID: 7816885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitated withdrawal in the substantia nigra in diazepam-dependent female rats.
    Wala EP; Sloan JW; Jing X; Holtman JR
    Pharmacol Biochem Behav; 1999 Dec; 64(4):857-68. PubMed ID: 10593210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice.
    Reddy DS; Kulkarni SK
    Psychopharmacology (Berl); 1996 Dec; 128(3):280-92. PubMed ID: 8972548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.